Generic Portal

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

Ramiro, S., Nikiphorou, E., Sepriano, A., Ortolan, A., Webers, C., Baraliakos, X., Landewé, R. B. M., van den Bosch, F. E., Boteva, B., Bremander, A., Carron, P., Ciurea, A., van Gaalen, F. A., Géher, P. L., Gensler, L., Hermann, J., de Hooge, M., Husakova, M., Kiltz, U., López-Medina, C., & 13 othersMachado, P. M., Marzo-Ortega, H., Molto, A., Navarro-Compán, V., Nissen, M. J., Pimentel-Santos, F. M., Poddubnyy, D., Proft, F., Rudwaleit, M., Telkman, M., Zhao, S. S., Ziade, N. & van der Heijde, D. S., 21 Oct 2022, In: Annals of the rheumatic diseases. 82, 1, p. 19-34 16 p., A78.

Research output: Contribution to journal › Article › Academic › peer-review

Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis

Webers, C., Ortolan, A., Sepriano, A., Falzon, L., Baraliakos, X., Landewé, R. B. M., Ramiro, S., van der Heijde, D. S. & Nikiphorou, E., 21 Oct 2022, In: Annals of the rheumatic diseases. 82, 1, p. 130-141 12 p., A80.

Research output: Contribution to journal › Review article › Academic › peer-review

Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis

Ortolan, A., Webers, C., Sepriano, A., Falzon, L., Baraliakos, X., Landewé, R. B. M., Ramiro, S., van der Heijde, D. S. & Nikiphorou, E., 19 Oct 2022, In: Annals of the rheumatic diseases. 82, 1, p. 142-152 11 p., A79.

Research output: Contribution to journal › Review article › Academic › peer-review

Favorable effect of a 'second hit' after 13 weeks in early RA non-responders: The Amsterdam COBRA treat-to-target randomized trial

Hartman, L., Rasch, L. A., Turk, S. A., Ter Wee, M. M., Kerstens, P. J. S. M., van der Laken, C. J., Nurmohamed, M. T., van Schaardenburg, D., van Tuyl, L. H. D., Voskuyl, A. E., Boers, M. & Lems, W. F., 7 Oct 2022, (E-pub ahead of print) In: Rheumatology (Oxford, England).

Research output: Contribution to journal › Article › Academic › peer-review

Sex differences in remission rates over 24 weeks among three different biological treatments compared to conventional therapy in patients with early rheumatoid arthritis (NORD-STAR): a post-hoc analysis of a randomised controlled trial

Lend, K., van Vollenhoven, R. F., Lampa, J., Lund Hetland, M., Haavardsholm, E. A., Nordström, D., Nurmohamed, M., Gudbjornsson, B., Rudin, A., Østergaard, M., Uhlig, T., Grondal, G., Hørslev-Petersen, K., Heiberg, M. S., Sokka-Isler, T., Koopman, F. A., Twisk, J. W. R. & van der Horst-Bruinsma, I., 1 Oct 2022, In: The Lancet Rheumatology. 4, 10, p. e688-e698

Research output: Contribution to journal › Article › Academic › peer-review

Improving naive B cell isolation by absence of CD45RB glycosylation and CD27 expression in combination with BCR isotype

Koers, J., Pollastro, S., Tol, S., Niewold, I. T. G., van Schouwenburg, P. A., de Vries, N. & Rispens, T., Oct 2022, In: European journal of immunology. 52, 10, p. 1630-1639 10 p.

Research output: Contribution to journal › Article › Academic › peer-review

Longitudinal analysis of anti-drug antibody development in multiple sclerosis patients treated with interferon beta-1a (Rebif™) using B cell receptor repertoire analysis

van der Weele, L., Pollastro, S., van Schaik, B. D. C., van Kampen, A. H. C., Niewold, I. T. G., Kuijpers, T. W., Warnke, C., Jensen, P. E. H., Kramer, D., Ryner, M., Hermanrud, C., Dönnes, P., Pallardy, M., Spindeldreher, S., on behalf of the ABIRISK Consortium, Deisenhammer, F., Fogdell-Hahn, A. & de Vries, N., 15 Sep 2022, In: Journal of neuroimmunology. 370, 577932.

Research output: Contribution to journal › Article › Academic › peer-review

Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus

LILAC Trial Investigators, 8 Sep 2022, In: The New England journal of medicine. 387, 10, p. 894-904 11 p.

Research output: Contribution to journal › Article › Academic › peer-review

Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases

Stalman, E. W., Wieske, L., van Dam, K. P. J., Kummer, L. Y., van Kempen, Z. L. E., Killestein, J., Volkers, A. G., Tas, S. W., Boekel, L., Wolbink, G. J., van der Kooi, A. J., Raaphorst, J., Löwenberg, M., Takkenberg, R. B., D'Haens, G. R. A. M., Spuls, P. I., Bekkenk, M. W., Musters, A. H., Post, N. F., Bosma, A. L., & 39 othersHilhorst, M. L., Vegting, Y., Bemelman, F. J., Voskuyl, A. E., Broens, B., Parra Sanchez, A., van Els, C. C. A. C. M., Wit, J. D., Rutgers, A., de Leeuw, K., Horváth, B., Verschuuren, J. J. G. M., Ruiter, A. M., van Ouwerkerk, L., van der Woude, D., Allaart, C. F., Teng, O. Y. K., van Paassen, P., Busch, M. H., Jallah, P. B. P., Brusse, E., van Doorn, P. A., Baars, A. E., Hijnen, D. J., Schreurs, C. R. G., van der Pol, W. L., Goedee, H. S., Steenhuis, M., Keijzer, S., Keijser, J. B. D., Boogaard, A., Cristianawati, O., ten Brinke, A., Verstegen, N. J. M., Zwinderman, K. A. H., Rispens, T., van Ham, S. M., Kuijpers, T. W. & Eftimov, F., 5 Sep 2022, In: Annals of the rheumatic diseases. 81, 12, p. 1757-1766 10 p., 222904.

Research output: Contribution to journal › Article › Academic › peer-review

Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis

Maksymowych, W. P., Baraliakos, X., Lambert, R. G., Landewé, R., Sandoval, D., Carlier, H., Lisse, J., Li, X., Hojnik, M. & Østergaard, M., 1 Sep 2022, In: The Lancet Rheumatology. 4, 9, p. e626-e634

Research output: Contribution to journal › Article › Academic › peer-review